Summary
Jonathan Cohen is a regulatory science leader and pharmacologist with over two decades of interdisciplinary experience spanning pharmacology, toxicology, neuroscience, microbiology, and bioinformatics. As Deputy Division Director for Pharmacology & Toxicology at the FDA, he oversees nonclinical review and regulatory strategy for diverse product classes including radiopharmaceuticals, medical imaging, and medical countermeasures, applying FDA and ICH guidance to complex decisions. His career blends bench research—from neural plasticity and muscle biology to comparative pathogenomics of Clostridium—with progressive regulatory roles at CBER and CDER, giving him a rare combination of hands-on science and policy expertise. He mentors review teams, contributes to guidance development and cross-center initiatives, and routinely presents internationally on nonclinical safety and product development. Based in Baltimore, he pairs a PhD in Pharmacology with practical bioinformatics skills and a DIY curiosity that surfaces in side projects bridging laboratory and computational approaches.
10 years of coding experience
10 years of employment as a software developer
Ph.D., Pharmacology, Ph.D., Pharmacology at University of Maryland Baltimore
BS, BIochemical Pharmacology, BS, BIochemical Pharmacology at University at Buffalo